세계의 헬스케어용 크로마토그래피 분석기 시장 보고서(2025년)
Healthcare Chromatography Analyzers Global Market Report 2025
상품코드 : 1810904
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

헬스케어용 크로마토그래피 분석기 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.1%로 19억 달러로 성장합니다. 예측 기간 중의 성장은 맞춤형 의료의 채택 증가, 하이스루풋 분석기에 대한 수요 증가, 치료제 모니터링에 대한 사용 확대, 대사체학 및 리피도믹스에 대한 관심 증가, 재택 진단 툴에 대한 수요 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 검출기 감도의 발전, 표적 치료를 위한 맞춤형 크로마토그래피 솔루션 개발, 크로마토그래피와 질량분석기의 통합, 실험실 자동화 시스템 도입, 분석 속도 향상을 위한 컬럼 기술 혁신 등을 들 수 있습니다.

만성질환의 유병률 증가는 헬스케어용 크로마토그래피 분석기 시장의 성장을 가속할 것으로 예측됩니다. 만성질환은 서서히 발병하고 지속적인 의학적 관리가 필요한 장기적인 질병입니다. 장시간 앉아서 생활하고 신체활동을 최소화하는 비활동적인 생활습관은 심장병, 당뇨병과 같은 질병의 발병률 증가의 원인이 되고 있습니다. 헬스케어용 크로마토그래피 분석기는 정확한 생체분자 분리를 가능하게 함으로써 진단 정확도 향상에 중요한 역할을 합니다. 이러한 툴은 바이오마커의 조기 발견과 추적에 필수적이며, 궁극적으로 임상 환경에서 질병 관리와 환자 결과를 개선하는 데 도움이 됩니다. 예를 들어 2024년 6월 영국 국립보건서비스(National Health Service)는 2023년 비당뇨병성 고혈당 또는 당뇨병 예비군으로 진단받은 361만 5,330명이 GP에 등록했다고 보고했으며, 이는 전년 대비 18% 증가한 수치입니다. 이러한 증가는 만성질환의 유병률 증가에 따른 헬스케어용 크로마토그래피 분석 장비에 대한 수요 증가를 보여줍니다.

헬스케어용 크로마토그래피 분석기 시장의 주요 기업은 고속 액체 크로마토그래피(HPLC) 시스템과 같은 차세대 제품을 개발하여 임상 진단 및 제약 연구의 정확성과 효율성을 향상시키고 있습니다. 이 첨단 툴은 복잡한 생체 시료 및 의약품 시료의 성분을 정확하게 분리, 식별, 정량화할 수 있도록 설계되었습니다. 예를 들어 Waters Corporation은 2024년 4월 바이오의약품 품질관리(QC) 실험실을 위해 설계된 차세대 플랫폼인 Alliance iS Bio HPLC 시스템을 출시했습니다. 이 시스템은 혁신적인 MaxPeak 고성능 표면(HPS) 기술을 통해 불필요한 분석물 상호 작용을 최소화하고, 직관적인 터치스크린 인터페이스와 가이드 워크플로우와 같은 인텔리전스가 내장되어 있으며, 인적 오류를 최대 40%까지 줄일 수 있습니다. 이러한 기능을 통해 보다 신속하고 신뢰할 수 있는 결과를 얻을 수 있으며, 바이오 제약 분야의 QC 실험실에 이상적인 선택이 될 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Healthcare chromatography analyzers are sophisticated instruments designed to separate, identify, and quantify substances in complex biological samples, such as blood, urine, or tissue extracts. These devices are essential in clinical diagnostics, pharmaceutical analysis, and biomarker detection, ensuring precise and high-resolution analysis to aid in disease diagnosis, drug monitoring, and therapeutic research within healthcare environments.

The primary types of healthcare chromatography analyzers include supercritical fluid chromatography, thin-layer chromatography, gas chromatography, and liquid chromatography systems. Supercritical fluid chromatography utilizes supercritical fluids as the mobile phase, offering more efficient separations and faster analysis times compared to traditional liquid chromatography. The consumables and accessories for these systems include flow management components, detectors, fraction collectors, fittings, pressure regulators, column accessories, autosamplers, mobile phase materials, and columns. These analyzers are used by a broad range of industries and institutions, such as pharmaceutical and biotechnology companies, academic research labs, life sciences sectors, hospitals, food and beverage industries, and environmental agencies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The healthcare chromatography analyzers market research report is one of a series of new reports from The Business Research Company that provides healthcare chromatography analyzers market statistics, including healthcare chromatography analyzers industry global market size, regional shares, competitors with a healthcare chromatography analyzers market share, detailed healthcare chromatography analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare chromatography analyzers industry. The healthcare chromatography analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare chromatography analyzers market size has grown strongly in recent years. It will grow from $1.48 billion in 2024 to $1.56 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to several factors, including the rising prevalence of chronic diseases, an increased focus on analytical testing in hospitals, higher demand for quality control in biologics, greater utilization in clinical trials, and growing government funding for life sciences research.

The healthcare chromatography analyzers market size is expected to see strong growth in the next few years. It will grow to $1.90 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine, a higher demand for high-throughput analyzers, expanding use in therapeutic drug monitoring, a growing focus on metabolomics and lipidomics, and rising demand for home-based diagnostic tools. Key trends in the forecast period include advancements in detector sensitivity, the development of custom chromatography solutions for targeted therapies, the integration of chromatography with mass spectrometry, the incorporation of lab automation systems, and innovations in column technology for faster analysis.

The rising prevalence of chronic diseases is expected to drive the growth of the healthcare chromatography analyzers market. Chronic diseases are long-lasting conditions that develop gradually and often require ongoing medical management. Inactive lifestyles, characterized by prolonged sitting and minimal physical activity, contribute to the growing incidence of conditions like heart disease and diabetes. Healthcare chromatography analyzers play a crucial role in improving diagnostic precision by enabling accurate biomolecular separation. These tools are vital for the early detection and tracking of biomarkers, ultimately enhancing disease management and patient outcomes in clinical environments. For example, in June 2024, the UK's National Health Service reported that 3,615,330 individuals diagnosed with non-diabetic hyperglycemia or pre-diabetes were registered with a GP in 2023, marking an 18% increase from the previous year. This increase highlights the growing demand for healthcare chromatography analyzers as the prevalence of chronic diseases rises.

Leading companies in the healthcare chromatography analyzers market are developing next-generation products, such as high-performance liquid chromatography (HPLC) systems, to improve accuracy and efficiency in clinical diagnostics and pharmaceutical research. These advanced tools are designed to separate, identify, and quantify components in complex biological and pharmaceutical samples with high precision. For example, in April 2024, Waters Corporation launched the Alliance iS Bio HPLC System, a next-gen platform designed for biopharmaceutical quality control (QC) labs. The system features innovative MaxPeak high-performance surfaces (HPS) technology to minimize unwanted analyte interactions, and built-in intelligence, including an intuitive touchscreen interface and guided workflows, which reduce human error by up to 40%. These features provide faster, more reliable results, making the system an ideal choice for QC labs in the biopharma sector.

In January 2022, Bruker Corporation, a US-based scientific instruments company, acquired Prolab Instruments GmbH to enhance its liquid chromatography portfolio. This acquisition strengthens Bruker's capabilities in single-cell and multi-omics workflows, particularly in the areas of proteomics and biomarker discovery. Prolab Instruments is a Switzerland-based company, specializes in nano- and micro-flow liquid chromatography systems tailored for healthcare applications.

Major players in the healthcare chromatography analyzers market are Hitachi Ltd., Merck and Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, GE Healthcare Life Sciences, Agilent Technologies Inc., Cytiva, PerkinElmer Inc., Shimadzu Corp, Waters Corp, Bio-Rad Laboratories Inc., Bruker Corp, Phenomenex Inc., Gilson Inc., Restek Corporation, Scion Instruments UK Ltd, Knauer GmbH, JASCO Corporation, E-Chrom Tech Co. Ltd., and SRI Instruments Inc.

North America was the largest region in the healthcare chromatography analyzers market in 2024. The regions covered in healthcare chromatography analyzers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the healthcare chromatography analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The healthcare chromatography analyzers market consists of sales of analytical columns, preparative columns, buffers, syringe filters, sample injectors, ultraviolet/visible detectors, and fluorescence detectors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Chromatography Analyzers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare chromatography analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for healthcare chromatography analyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The healthcare chromatography analyzers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Healthcare Chromatography Analyzers Market Characteristics

3. Healthcare Chromatography Analyzers Market Trends And Strategies

4. Healthcare Chromatography Analyzers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Healthcare Chromatography Analyzers Growth Analysis And Strategic Analysis Framework

6. Healthcare Chromatography Analyzers Market Segmentation

7. Healthcare Chromatography Analyzers Market Regional And Country Analysis

8. Asia-Pacific Healthcare Chromatography Analyzers Market

9. China Healthcare Chromatography Analyzers Market

10. India Healthcare Chromatography Analyzers Market

11. Japan Healthcare Chromatography Analyzers Market

12. Australia Healthcare Chromatography Analyzers Market

13. Indonesia Healthcare Chromatography Analyzers Market

14. South Korea Healthcare Chromatography Analyzers Market

15. Western Europe Healthcare Chromatography Analyzers Market

16. UK Healthcare Chromatography Analyzers Market

17. Germany Healthcare Chromatography Analyzers Market

18. France Healthcare Chromatography Analyzers Market

19. Italy Healthcare Chromatography Analyzers Market

20. Spain Healthcare Chromatography Analyzers Market

21. Eastern Europe Healthcare Chromatography Analyzers Market

22. Russia Healthcare Chromatography Analyzers Market

23. North America Healthcare Chromatography Analyzers Market

24. USA Healthcare Chromatography Analyzers Market

25. Canada Healthcare Chromatography Analyzers Market

26. South America Healthcare Chromatography Analyzers Market

27. Brazil Healthcare Chromatography Analyzers Market

28. Middle East Healthcare Chromatography Analyzers Market

29. Africa Healthcare Chromatography Analyzers Market

30. Healthcare Chromatography Analyzers Market Competitive Landscape And Company Profiles

31. Healthcare Chromatography Analyzers Market Other Major And Innovative Companies

32. Global Healthcare Chromatography Analyzers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Chromatography Analyzers Market

34. Recent Developments In The Healthcare Chromatography Analyzers Market

35. Healthcare Chromatography Analyzers Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기